Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Should You Buy Bionano Genomics Stock?

TheMotleyFool

0 0

You won't find too many hotter stocks on the market right now than Bionano Genomics (NASDAQ: BNGO). In 2020, shares of the genome analysis company soared 148%. What makes that gain even more impressive is that Bionano was down 55% year to date as of Dec. 22. The stock's remarkable jump came in the last few days of the year.

It gets even better. Bionano stock has more than quadrupled so far in 2021. The company's market cap has skyrocketed more than 600%, generating stronger growth than its share price because of two diluting stock offerings. Should you buy Bionano Genomics? Or is this sizzling healthcare stock too hot to handle?

Image source: Getty Images.

Source Fool.com

Like: 0

BNGO

Share